Transforming lives through novel therapies for neurology and oncology.

  • Insight
  • Discovery
  • Passion

Cavion is a clinical-stage pharmaceutical company developing best-in-class T-type calcium channel (Cav3) therapies for neurology and oncology.  At Cavion, we combine our nuanced understanding of Cav3 biology with superior chemistry and world-class clinical development expertise to develop novel therapeutics that will transform patients’ lives. 

Learn More

Cavion’s pipeline is comprised of best-in-class Cav3 modulators obtained from both internal drug discovery and in-licensing efforts.

Learn More

Our deep insight into the biology and function of Cav3 has led us to pursue promising indications for our best-in-class Cav3 therapies.  Our mission is to create significant improvements to the lives of patients.

Learn More

Latest News

More +

Contact Us

Cavion